Frontlight ResearchEarly access
Trial site
Florida International Research Center
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Tourette syndrome2 trials
- Atopic dermatitis (eczema)1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 34 trials
- Phase 11 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Emalex Biosciences Inc.2 trials
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026